Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127214731 | 12721473 | 1 | I | 20160330 | 20160822 | 20160907 | 20160907 | EXP | CH-GILEAD-2016-0230157 | GILEAD | 47.00 | YR | A | F | Y | 49.00000 | KG | 20160907 | MD | CH | CH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127214731 | 12721473 | 1 | PS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 1 DF, UNK | 21752 | 1 | DF | TABLET | |||||||
| 127214731 | 12721473 | 2 | C | ATAZANAVIR W/RITONAVIR | ATAZANAVIRRITONAVIR | 1 | 0 | ||||||||||||
| 127214731 | 12721473 | 3 | C | DOLOPHINE | METHADONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127214731 | 12721473 | 4 | C | TRANXILIUM | CLORAZEPATE DIPOTASSIUM | 1 | 0 | ||||||||||||
| 127214731 | 12721473 | 5 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | 0 | ||||||||||||
| 127214731 | 12721473 | 6 | C | WELLVONE | ATOVAQUONE | 1 | 0 | ||||||||||||
| 127214731 | 12721473 | 7 | C | PREZISTA | DARUNAVIR ETHANOLATE | 1 | 0 | ||||||||||||
| 127214731 | 12721473 | 8 | C | NORVIR | RITONAVIR | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127214731 | 12721473 | 1 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127214731 | 12721473 | HO |
| 127214731 | 12721473 | OT |
| 127214731 | 12721473 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127214731 | 12721473 | Agnosia | |
| 127214731 | 12721473 | Apraxia | |
| 127214731 | 12721473 | Cognitive disorder | |
| 127214731 | 12721473 | Hemiparesis | |
| 127214731 | 12721473 | Memory impairment | |
| 127214731 | 12721473 | Varicella zoster virus infection | |
| 127214731 | 12721473 | Vasculitis cerebral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127214731 | 12721473 | 1 | 20160119 | 0 |